Alto Neuroscience Announces Participation in Upcoming Investor Conferences
Business Wire (Mon, 23-Feb 8:33 AM ET)
Business Wire (Fri, 13-Feb 8:04 AM ET)
Business Wire (Tue, 3-Feb 8:27 AM ET)
Globe Newswire (Tue, 20-Jan 9:31 AM ET)
Business Wire (Wed, 14-Jan 7:27 AM ET)
Business Wire (Tue, 13-Jan 8:00 AM ET)
Alto Neuroscience Announces New Employee Inducement Grants Under NYSE Rule 303A.08
Business Wire (Wed, 3-Dec 4:05 PM ET)
Globe Newswire (Mon, 1-Dec 5:42 PM ET)
Alto Neuroscience Secures $50 Million to Fast-Track Key Depression Drug: Here’s What Stands Out
Market Chameleon (Mon, 20-Oct 3:54 AM ET)
Market Chameleon (Fri, 3-Oct 6:29 AM ET)
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
Alto Neuroscience trades on the NYSE stock market under the symbol ANRO.
As of February 24, 2026, ANRO stock price climbed to $19.32 with 213,914 million shares trading.
ANRO has a beta of 2.03, meaning it tends to be more sensitive to market movements. ANRO has a correlation of 0.09 to the broad based SPY ETF.
ANRO has a market cap of $600.20 million. This is considered a Small Cap stock.
The top ETF exchange traded funds that ANRO belongs to (by Net Assets): VTI, VXF, IBB, IWC, PSIL.
ANRO has outperformed the market in the last year with a price return of +505.6% while the SPY ETF gained +15.8%. ANRO has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +45.8% and +14.7%, respectively, while the SPY returned +4.6% and -1.0%, respectively.
ANRO support price is $17.04 and resistance is $19.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ANRO shares will trade within this expected range on the day.
